Drug for Early Alzheimer’s Heads to Clinical Trial

Check back often to find the latest news on AgeneBio and our pipeline of multiple candidates.

« back to Press Releases

September 20, 2015

Drug for Early Alzheimer’s Heads to Clinical Trial

Johns Hopkins University researchers have received an estimated $7.5 million National Institutes of Health grant to clinically test what would be the first treatment to prevent or delay the onset of Alzheimer’s dementia.